|New to this edition|
- A practical new configuration featuring an expanded electronic version (both online and eBook format) in addition to a one-volume condensed print version.
- New content includes 12 new epilepsy chapters, 5 new cerebrovascular chapters, and 13 new neurooncology chapters, as well as new chapters on neuroimmunology and neuromuscular disorders, as well as chapters focused on clinical care (e.g., Counseling Families, Practice Guidelines, Transitional Care, Personalized Medicine, Special Educational Law, Outcome Measurements, Neurorehabilitation, Impact of Computer Resources, and Training Issues).
- Additional new chapters cover topics related to the developmental connectome, stem cell transplantation, and cellular and animal models of neurological disease.
- Greatly expanded sections to increase your knowledge of perinatal acquired and congenital disorders, neurodevelopmental disabilities, pediatric epilepsy, and nonepileptiform paroxysmal disorders and disorders of sleep.
- Coverage of new, emerging, or controversial topics includes developmental encephalopathies, non-verbal learning disorders, and the pharmacological and future genetic treatment of neurodevelopmental disabilities.
|By Kenneth F. Swaiman, MD, Director Emeritus, Division of Pediatric Neurology, Professor Emeritus of Neurology and Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota; Stephen Ashwal, MD, Distinguished Professor of Pediatrics, Chief of the Division of Child Neurology and Pediatrics, Loma Linda University School of Medicine, Loma Linda, California; Donna M Ferriero, MD MS, W.H. and Marie Wattis Distinguished Professor and Chair, Department of Pediatrics, Physician-in-Chief, USCF Benioff Children's Hospital, University of California, San Francisco, California; Nina F Schor, MD, PhD, William H. Eilinger Professor and Chair, Department of Pediatrics, Professor, Department of Neurology, Pediatrician-in-Chief, Golisano Children’s Hospital, University of Rochester Medical Center, Rochester, New York ; Richard S Finkel; Andrea L Gropman, MD, Chief, Neurogenetics and Neurodevelopmental Disabilities, Department of Neurology, Children’s National Medical Center and the George Washington University of the Health Sciences, Washington, D.C. ; Phillip L Pearl, Director of Epilepsy and Clinical Neurophysiology, William G. Lennox Chair and Professor of Neurology, Harvard Medical School and Michael Shevell, MDCM, FRCP(C), FANA, FAAN, Chair, McGill Department of Pediatrics, Pediatrician-in-Chief, Montreal Children's Hospital-McGill University Health Centre (MUHC), Harvey Guyda Professor, Montreal, Quebec, Canada|